Pictet Asset Management (Switzerland)’s AstraZeneca AZN Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$121M	Buy	847,168 +98,860	+13%	+$14.5M	0.14%	177
2023 Q1	$104M	Buy	748,308 +492,154	+192%	+$66.2M	0.13%	193
2022 Q4	$34.7M	Buy	256,154 +64,847	+34%	+$8.13M	0.05%	331
2022 Q3	$21M	Sell	191,307 -25,519	-12%	-$3.24M	0.03%	417
2022 Q2	$28.7M	Buy	216,826 +6,676	+3%	+$876K	0.04%	389
2022 Q1	$27.9M	Buy	210,150 +4,527	+2%	+$543K	0.03%	429
2021 Q4	$24M	Sell	205,623 -97,618	-32%	-$11.5M	0.02%	484
2021 Q3	$73.3M	Buy	+303,241	New	+$35.3M	0.08%	273

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s AZN Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its AstraZeneca (AZN) stake by 13% in Q2 2023, buying an estimated $14.5M and bringing the position to 847,168 shares worth $121M. The position accounts for 0.14% of the portfolio, ranked #177.

Pictet Asset Management (Switzerland) first reported a position in AZN in Q3 2021 and has held it in 8 quarters since. 1,092 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

Pictet Asset Management (Switzerland) held 847,168 shares of AstraZeneca worth $121M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 98,860 AstraZeneca shares in Q2 2023, an estimated $14.5M.
AstraZeneca made up 0.14% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #177 holding.
Pictet Asset Management (Switzerland) first reported a position in AstraZeneca in Q3 2021 and has held it in 8 quarters since.
1,092 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.